Tal Medical

Developer of non-contact, neuromodulatory device for the treatment of psychiatric and neurological disorders.

Launch date

Jan 2011

Employees

Market cap

Enterprise valuation

Boston Massachusetts (HQ)

Date	Investors	Amount	Round
Jun 2011	N/A	$700k	Debt
Mar 2014	N/A	$2.8m	Series A
Apr 2015	PureTech	$14.0m	Series A
Total Funding		AUD25.9m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Tal Medical